Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity.

Mild Behavioral Impairment (MBI) aging apathy cognitive impairment dementia

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
21 Aug 2023
Historique:
received: 17 06 2023
revised: 09 08 2023
accepted: 14 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

The Mild Behavioral Impairment (MBI) concept was developed to determine whether late-onset persistent neuropsychiatric symptoms (NPSs) may be early manifestations of cognitive decline. Our study aims to investigate the prevalence and differentiating features of MBI with respect to major neurocognitive disorders (MNDs) and primary psychiatric disorders (PPDs). A total of 144 elderly patients who were referred to our psychogeriatric outpatient service were recruited. The severity of mental illness was evaluated by means of the Clinical Global Impression Severity scale, the severity of psychopathology was evaluated by means of the Brief Psychiatric Rating Scale (BPRS), and overall functioning was evaluated by means of the Global Assessment of Functioning scale. The sample included 73 (50.6%) patients with PPDs, 40 (27.8%) patients with MBI, and 31 (21.5%) patients with MNDs. Patients with MNDs reported the greatest severity of mental illness, the highest BPRS Total, Psychosis, Activation, and Negative Symptom scores, and the lowest functioning. Patients with MBI and PPDs had comparable levels of severity of mental illness and overall functioning, but MBI patients reported higher BPRS Total and Negative Symptom scores than PPD patients. Patients with MBI frequently reported specific clinical features, including a higher severity of apathy and motor retardation. These features merit further investigation since they may help the differential diagnosis between MBI and PPDs.

Identifiants

pubmed: 37629464
pii: jcm12165423
doi: 10.3390/jcm12165423
pmc: PMC10455739
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Psychogeriatrics. 2021 Jan;21(1):100-111
pubmed: 33260271
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Aging Ment Health. 2018 Dec;22(12):1577-1584
pubmed: 29077487
J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):619-24
pubmed: 17717021
Front Psychiatry. 2021 Feb 26;12:638651
pubmed: 33716830
Clin Ther. 2022 Nov;44(11):1449-1462
pubmed: 36210219
Int J Geriatr Psychiatry. 2021 Sep;36(9):1398-1406
pubmed: 33778998
Psychiatr Danub. 2010 Nov;22 Suppl 1:S108-10
pubmed: 21057414
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Sci Transl Med. 2011 Nov 30;3(111):111cm33
pubmed: 22133718
Am J Geriatr Psychiatry. 2008 Sep;16(9):770-6
pubmed: 18757769
Alzheimers Res Ther. 2016 Jul 30;8(1):23
pubmed: 27473681
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
Front Aging Neurosci. 2021 May 24;13:643271
pubmed: 34108874
Dialogues Clin Neurosci. 2008;10(3):345-57
pubmed: 18979948
Alzheimers Dement. 2016 Feb;12(2):195-202
pubmed: 26096665
J Affect Disord. 2019 May 1;250:410-418
pubmed: 30878653
CNS Neurol Disord Drug Targets. 2009 Apr;8(2):144-59
pubmed: 19355934
Neurology. 2023 Feb 14;100(7):e683-e693
pubmed: 36323521
Alzheimers Dement. 2021 Dec;17(12):1892-1904
pubmed: 33949763
J Affect Disord. 1988 Nov-Dec;15(3):255-68
pubmed: 2975298
PLoS Med. 2017 Mar 28;14(3):e1002275
pubmed: 28350794
Alzheimers Dement. 2017 Jan;13(1):59-71
pubmed: 27693188
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
Alzheimers Dement. 2022 Nov;18(11):2199-2208
pubmed: 35103400
J Intern Med. 2014 Mar;275(3):214-28
pubmed: 24605806
Biomed Res Int. 2014;2014:908915
pubmed: 25089278
Lancet Public Health. 2018 Sep;3(9):e447-e455
pubmed: 30174210
Nat Rev Neurol. 2022 Jul;18(7):389-399
pubmed: 35379951
Lancet Public Health. 2022 Feb;7(2):e105-e125
pubmed: 34998485
Transl Psychiatry. 2022 Mar 26;12(1):124
pubmed: 35347114
Int Psychogeriatr. 2022 Feb 08;:1-10
pubmed: 35130991
J Alzheimers Dis. 2021;80(1):459-469
pubmed: 33554909
Int Psychogeriatr. 2020 Mar;32(3):381-392
pubmed: 31455461
J Affect Disord. 2000 Jun;58(3):215-21
pubmed: 10802130
J Alzheimers Dis. 2011;26 Suppl 3:321-9
pubmed: 21971471
Curr Neuropharmacol. 2022 Jul 06;:
pubmed: 35794767
J Affect Disord. 2023 Jul 1;332:9-18
pubmed: 36997127
Ann Rehabil Med. 2022 Apr;46(2):53-59
pubmed: 35508924
Cold Spring Harb Perspect Med. 2012 May;2(5):a006148
pubmed: 22553492
Alzheimers Dement (N Y). 2022 Dec 19;8(1):e12370
pubmed: 36544988
Psychiatry Res. 2005 Jun 30;135(3):217-28
pubmed: 15993949
J Alzheimers Dis. 2018;66(1):83-95
pubmed: 30175974
Am J Psychiatry. 2014 May;171(5):572-81
pubmed: 24700290
J Geriatr Psychiatry Neurol. 2023 Mar;36(2):107-120
pubmed: 35430902
Am J Geriatr Psychiatry. 2014 Dec;22(12):1642-51
pubmed: 24698445
J Alzheimers Dis. 2019;70(2):505-513
pubmed: 31177229
Front Psychiatry. 2021 Dec 20;12:792168
pubmed: 34987434
Ann Indian Acad Neurol. 2014 Apr;17(2):147-54
pubmed: 25024563
Am J Geriatr Psychiatry. 2019 Aug;27(8):823-834
pubmed: 30902566
Br J Psychiatry. 1995 May;166(5):654-9
pubmed: 7620753
Lancet Psychiatry. 2016 Jul;3(7):628-35
pubmed: 27138970
Int J Geriatr Psychiatry. 2009 Apr;24(4):341-6
pubmed: 18814198
J Alzheimers Dis. 2015;48(2):483-93
pubmed: 26402012
JAMA Psychiatry. 2017 Jul 1;74(7):712-718
pubmed: 28514478
Riv Psichiatr. 2019 Mar-Apr;54(2):59-66
pubmed: 30985830
Biol Psychiatry. 1993 Aug 1;34(3):141-5
pubmed: 8399805
Cereb Circ Cogn Behav. 2021 Sep 14;2:100028
pubmed: 36324720
Acta Neurol Belg. 2022 Dec;122(6):1493-1497
pubmed: 34191260
J Alzheimers Dis. 2010;20(1):175-83
pubmed: 20164594
Front Aging Neurosci. 2022 Oct 10;14:937486
pubmed: 36299608

Auteurs

Camilla Elefante (C)

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Giulio Emilio Brancati (GE)

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Zahinoor Ismail (Z)

Departments of Psychiatry, Clinical Neurosciences, Community Health Sciences, and Pathology and Laboratory Medicine, Hotchkiss Brain Institute & O'Brien Institute for Public Health, University of Calgary, Calgary, AB T2N 1N4, Canada.
College of Health and Medicine, University of Exeter, Exeter EX4 4QG, UK.

Sara Ricciardulli (S)

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Maria Francesca Beatino (MF)

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Vittoria Lepri (V)

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.

Antonella Famà (A)

Psychiatry Unit, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.

Elisabetta Ferrari (E)

Psychiatry Unit, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.

Linda Giampietri (L)

Neurology Unit, Santa Chiara University Hospital, 56126 Pisa, Italy.

Filippo Baldacci (F)

Neurology Unit, Santa Chiara University Hospital, 56126 Pisa, Italy.

Roberto Ceravolo (R)

Neurology Unit, Santa Chiara University Hospital, 56126 Pisa, Italy.

Icro Maremmani (I)

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
G. De Lisio Institute of Behavioral Sciences, 56127 Pisa, Italy.
Addiction Medicine, Saint Camillus International University of Health and Medical Sciences (UniCamillus), 00131 Rome, Italy.

Lorenzo Lattanzi (L)

Psychiatry Unit, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy.

Giulio Perugi (G)

Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
G. De Lisio Institute of Behavioral Sciences, 56127 Pisa, Italy.

Classifications MeSH